Particularly, Chen and collaborators described by means of cellular experiments that filaggrin is an oncogene in bladder urothelial carcinoma (BLCA), and that a knockdown of this barrier protein suppressed BLCA cell proliferation and promoted apoptosis (133). The gene discussed is FLG; the disease is bladder transitional cell carcinoma.